news El Financiero 2026-07-21

Ozempic Sues Eli Lilly Over 'Deceptive' Weight Loss Claims Using Outdated Studies

Novo Nordisk, maker of Ozempic, has sued competitor Eli Lilly for allegedly deceptive advertising regarding weight loss drugs. The lawsuit claims Eli Lilly used outdated studies to promote its products, Zepbound and Mounjaro.

Support Your Local Toad

The Pesky Toad is free and ad-light. If you find it useful, toss a few pesos in the tip jar to help keep the servers running and the satire flowing.

$

MXN · Minimum $10